ARTICLE | Company News
Intas Pharmaceuticals Ltd, Roche cancer news
July 15, 2013 7:00 AM UTC
Roche granted Intas' Accord Healthcare Ltd. subsidiary rights to market a generic version of Roche's Xeloda capecitabine in the U.S. ahead of the Dec. 14, 2013, expiration of the patent covering Xelo...